Dominion Energy (NYSE:D) reported quarterly earnings of $0.76 per share which missed the analyst consensus estimate of $0.77 by 1.3 percent. This is a 7.32 percent decrease over earnings of $0.82 per share from the same period last year. The company reported $3.04 billion in sales this quarter.
Taysha Gene Therapies Reports Clinical Efficacy And Safety Data For High Dose Cohort And Long-term Durability Data For TSHA-120 In Giant Axonal Neuropathy
Taysha Gene Therapies, Inc. (NASDAQ:TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central
